Catamaran Bio
Angela Nunez is a highly skilled professional with a background in preclinical pharmacology. With a Master of Business Administration and a Bachelor of Business Administration in Health Care Administration/Management, Angela has held various roles in different companies such as Catamaran Bio, KSQ Therapeutics, bluebird bio, Pfizer, and Massachusetts General Hospital. Throughout their career, Angela has demonstrated expertise in in vivo techniques, study design, data analysis, and animal health monitoring. Angela Nunez's experience and education have equipped their to excel in their role as a Senior Manager Preclinical - Pharmacology at Catamaran Bio.
Catamaran Bio
Catamaran Bio is a newly-formed biotechnology company funded by SV Health Investors. Catamaran is developing transformative off-the-shelf CAR-NK cell therapies.